GENMAB A/S: Financial statements 2025
CVR: 21023884
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
GENMAB A/S (CVR 21023884) has filed annual accounts for 2025. In 2025, the company reported revenue of USD 3,720,000,000 and a net result of USD 963,000,000 compared with DKK 7,844,000,000 the year before. That is a decrease of 82.7% compared with the year before. The profit margin was 25.9%. Equity in the 2025 report amounted to USD 5,847,000,000. The solvency ratio was 45.4%. The company had 2,694 employees in the financial year.
- Revenue
- USD 3,720,000,000
- Profit/Loss
- USD 963,000,000
- Equity
- USD 5,847,000,000
- Total Assets
- USD 12,873,000,000
- Employees
- 2,694
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 3.7 mia. USD | - | 963 mio. USD | 5.8 mia. USD | 2694 |
| 2024 | 21.5 mia. | - | 7.8 mia. | 36.7 mia. | 2011 |
| 2023 | 16.5 mia. | - | 4.4 mia. | 31.6 mia. | 2011 |
| 2022 | 14.6 mia. | - | 5.5 mia. | 27.4 mia. | 313 |
| 2021 | 8.5 mia. | - | 3 mia. | 22.2 mia. | 235 |
Official annual report
How creditworthy is GENMAB A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
GENMAB A/S has published its interim report for the period January 1, 2025 – September 30, 2025.
GENMAB A/S has published its interim report for the period January 1, 2025 – June 30, 2025.
GENMAB A/S has published its interim report for the period January 1, 2025 – March 31, 2025.
GENMAB A/S has published its annual report for 2024. Revenue came to DKK 21,526,000,000, and the net result was DKK 7,844,000,000.
As of March 12, 2025, Ogi Takahashi has joined the board of directors of GENMAB A/S.
As of March 12, 2025, Gina Theresa Schweizer has joined the board of directors of GENMAB A/S.
As of March 12, 2025, Michael Arthur Kavanagh has joined the board of directors of GENMAB A/S.
As of March 12, 2025, Martha Theresa Ramirez-Andersen has joined the board of directors of GENMAB A/S.
As of March 12, 2025, Julie Blædel has left the board of directors of GENMAB A/S.
As of March 12, 2025, Richard Gordon Hibbert has left the board of directors of GENMAB A/S.
About GENMAB A/S
GENMAB A/S is a Danish company of the type Aktieselskab based in Valby, founded in 1998. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named GFKJUS 519 ApS. The management consists of Jan van de Winkel and Anthony Michael Pagano. The board consists of Deirdre Patrice Connelly (chair), Pernille Lyngvold Erenbjerg, Anders Gersel Pedersen and Elizabeth Grimes O’Farrell. The company is owned by BLACKROCK, INC. and Darwin Global Management Limited. The company has 676 employees (2026). In 2025, the company reported revenue of USD 3,720,000,000 and a net result of USD 963,000,000 compared with DKK 7,844,000,000 the year before. Equity in the 2025 report amounted to USD 5,847,000,000.